| Related Articles |
Immune-Related Adverse Events: Pneumonitis.
Adv Exp Med Biol. 2018;995:131-149
Authors: Jain A, Shannon VR, Sheshadri A
Abstract
Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct patterns. The goal of this chapter is to instruct readers on the incidence and clinical manifestations of pneumonitis and to offer guidance in the evaluation and treatment of patients with pneumonitis.
PMID: 30539509 [PubMed - in process]
from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2EjhiUH
No comments:
Post a Comment